0.79
0.79 (0%)
As of Dec 18, 2023
Fresh Tracks Therapeutics, Inc. [FRTX]
Source:
Company Overview
Fresh Tracks Therapeutics, Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics. Our pipeline aimed to disrupt existing treatment paradigms and featured several new chemical entities that inhibit novel targets with first-in-class potential for autoimmune, inflammatory, and other debilitating diseases.
| Country | United States |
| Headquarters | boulder, colorado |
| Phone Number | ( 720 ) 505-4755 |
| Industry | manufacturing |
| CEO | Albert N. Marchio, Ii |
| Website | www.frtx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $8 |
| Operating Profit | $-6.4 |
| Net Income | $-5.7 |
| Net Cash | $2.2 |
Profit Ratios
| Gross Margin | $8 |
| Operating Margin | -79.4 |
| Profit as % of Revenues | -140.6% |
| Profit as % of Assets | -58.1% |
| Profit as % of Stockholder Equity | -57.3% |
Management Effectiveness
| Return on Equity | -57.3% |
| Return on Assets | -49.2% |
| Turnover Ratio | 81.7% |
| EBITA | $-6.4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $11.6 |
| Total Liabilities | $1.7 |
| Operating Cash Flow | $-4.3 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $6.5 |
